DURECT logo

DURECT

1 follower

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Industries

Employees

51-200

Links


Org chart

James E. Brown
President & CEO
Collapse
Judy Joice
SVP, Operations & Corporate Quality Assurance
Weiqi Lin
EVP, Research & Development & Principal Scientist
Charlie Claycomb
Executive Director Information Technology

Board & advisors

Judith J. Robertson
Board Member - Chair of Nominating and Governance Committee
Peter Garcia
Director
Gail J. Maderis
Chair of the Board